APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Enoxaparin Sodium Injection Industry Growth and Trends Forecast to 2032

20 December 2025118 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Injection Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Injection Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Injection Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Injection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Enoxaparin Sodium Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enoxaparin Sodium Injection include Teva, Suzhou Erye Pharmaceutical, Sandoz, Sanofi, Nanjing King-friend, Hangzhou Jiuyuan Gene Engineering, Hebei Changshan Biochemical Pharmaceutical, Fresenius Kabi and Changzhou Qianhong Bio-pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Enoxaparin Sodium Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enoxaparin Sodium Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enoxaparin Sodium Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enoxaparin Sodium Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Enoxaparin Sodium Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enoxaparin Sodium Injection Market by Company

Teva

Suzhou Erye Pharmaceutical

Sandoz

Sanofi

Nanjing King-friend

Hangzhou Jiuyuan Gene Engineering

Hebei Changshan Biochemical Pharmaceutical

Fresenius Kabi

Changzhou Qianhong Bio-pharma

Beijing SL Pharmaceutical

Chengdu Baiyu Pharmaceutical

Techdow (Hepalink)

Taj Pharma

Rovi

Cipla

Apotex

Amphastar

Enoxaparin Sodium Injection Segment by Type

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

20 mg/0.2mL

30 mg/0.3mL

300mg/3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

Enoxaparin Sodium Injection Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enoxaparin Sodium Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Enoxaparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100 mg/1mL Table 2. Major Company of 120 mg/0.8mL Table 3. Major Company of 150 mg/1mL Table 4. Major Company of 20 mg/0.2mL Table 5. Major Company of 30 mg/0.3mL Table 6. Major Company of 300mg/3mL Table 7. Major Company of 40 mg/0.4mL Table 8. Major Company of 60 mg/0.6mL Table 9. Major Company of 80 mg/0.8mL Table 10. Global Enoxaparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 11. Global Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 12. Global Enoxaparin Sodium Injection Sales Market Share in Volume by Type (2021-2026) Table 13. Global Enoxaparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 14. Global Enoxaparin Sodium Injection Sales Market Share in Value by Type (2021-2026) Table 15. Global Enoxaparin Sodium Injection Price by Type (2021-2026) & (US$/Unit) Table 16. Global Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 17. Global Enoxaparin Sodium Injection Sales Market Share in Volume by Type (2027-2032) Table 18. Global Enoxaparin Sodium Injection Sales by Type (2027-2032) & (US$ Million) Table 19. Global Enoxaparin Sodium Injection Sales Market Share in Value by Type (2027-2032) Table 20. Global Enoxaparin Sodium Injection Price by Type (2027-2032) & (US$/Unit) Table 21. North America Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 22. North America Enoxaparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Europe Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 24. Europe Enoxaparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Asia-Pacific Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 26. Asia-Pacific Enoxaparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 27. Latin America Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 28. Latin America Enoxaparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 29. Middle East and Africa Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 30. Middle East and Africa Enoxaparin Sodium Injection Sales by Type (2021-2026) & (US$ Million) Table 31. Enoxaparin Sodium Injection Industry Trends Table 32. Enoxaparin Sodium Injection Industry Drivers Table 33. Enoxaparin Sodium Injection Industry Opportunities and Challenges Table 34. Enoxaparin Sodium Injection Industry Restraints Table 35. Global Enoxaparin Sodium Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 36. Global Enoxaparin Sodium Injection Revenue Market Share by Company (2021-2026) Table 37. Global Enoxaparin Sodium Injection Sales by Company (2021-2026) & (K Units) Table 38. Global Enoxaparin Sodium Injection Sales Share by Company (2021-2026) Table 39. Global Enoxaparin Sodium Injection Market Price by Company (2021-2026) & (US$/Unit) Table 40. Global Enoxaparin Sodium Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 41. Global Enoxaparin Sodium Injection Major Company Production Sites and Headquarters Table 42. Global Enoxaparin Sodium Injection Company, Product Type & Application Table 43. Global Enoxaparin Sodium Injection Company Establishment Date Table 44. Global Company Market Concentration Ratio (CR5 and HHI) Table 45. Global Enoxaparin Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 46. Global Enoxaparin Sodium Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 47. Global Enoxaparin Sodium Injection Sales by Region (2021-2026) & (K Units) Table 48. Global Enoxaparin Sodium Injection Sales Market Share in Volume by Region (2021-2026) Table 49. Global Enoxaparin Sodium Injection Sales by Region (2021-2026) & (US$ Million) Table 50. Global Enoxaparin Sodium Injection Sales Market Share in Value by Region (2021-2026) Table 51. Global Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 52. Global Enoxaparin Sodium Injection Sales by Region (2027-2032) & (K Units) Table 53. Global Enoxaparin Sodium Injection Sales Market Share in Volume by Region (2027-2032) Table 54. Global Enoxaparin Sodium Injection Sales by Region (2027-2032) & (US$ Million) Table 55. Global Enoxaparin Sodium Injection Sales Market Share in Value by Region (2027-2032) Table 56. Global Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 57. Global Enoxaparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 58. Global Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 59. Global Enoxaparin Sodium Injection Sales Market Share in Volume by Application (2021-2026) Table 60. Global Enoxaparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 61. Global Enoxaparin Sodium Injection Sales Market Share in Value by Application (2021-2026) Table 62. Global Enoxaparin Sodium Injection Price by Application (2021-2026) & (US$/Unit) Table 63. Global Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 64. Global Enoxaparin Sodium Injection Sales Market Share in Volume by Application (2027-2032) Table 65. Global Enoxaparin Sodium Injection Sales by Application (2027-2032) & (US$ Million) Table 66. Global Enoxaparin Sodium Injection Sales Market Share in Value by Application (2027-2032) Table 67. Global Enoxaparin Sodium Injection Price by Application (2027-2032) & (US$/Unit) Table 68. North America Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 69. North America Enoxaparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Europe Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 71. Europe Enoxaparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Asia-Pacific Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 73. Asia-Pacific Enoxaparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 74. Latin America Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 75. Latin America Enoxaparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 76. Middle East and Africa Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 77. Middle East and Africa Enoxaparin Sodium Injection Sales by Application (2021-2026) & (US$ Million) Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teva Enoxaparin Sodium Injection Product Portfolio Table 82. Teva Recent Development Table 83. Suzhou Erye Pharmaceutical Company Information Table 84. Suzhou Erye Pharmaceutical Business Overview Table 85. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 87. Suzhou Erye Pharmaceutical Recent Development Table 88. Sandoz Company Information Table 89. Sandoz Business Overview Table 90. Sandoz Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sandoz Enoxaparin Sodium Injection Product Portfolio Table 92. Sandoz Recent Development Table 93. Sanofi Company Information Table 94. Sanofi Business Overview Table 95. Sanofi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sanofi Enoxaparin Sodium Injection Product Portfolio Table 97. Sanofi Recent Development Table 98. Nanjing King-friend Company Information Table 99. Nanjing King-friend Business Overview Table 100. Nanjing King-friend Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio Table 102. Nanjing King-friend Recent Development Table 103. Hangzhou Jiuyuan Gene Engineering Company Information Table 104. Hangzhou Jiuyuan Gene Engineering Business Overview Table 105. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio Table 107. Hangzhou Jiuyuan Gene Engineering Recent Development Table 108. Hebei Changshan Biochemical Pharmaceutical Company Information Table 109. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 110. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 112. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 113. Fresenius Kabi Company Information Table 114. Fresenius Kabi Business Overview Table 115. Fresenius Kabi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio Table 117. Fresenius Kabi Recent Development Table 118. Changzhou Qianhong Bio-pharma Company Information Table 119. Changzhou Qianhong Bio-pharma Business Overview Table 120. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio Table 122. Changzhou Qianhong Bio-pharma Recent Development Table 123. Beijing SL Pharmaceutical Company Information Table 124. Beijing SL Pharmaceutical Business Overview Table 125. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 127. Beijing SL Pharmaceutical Recent Development Table 128. Chengdu Baiyu Pharmaceutical Company Information Table 129. Chengdu Baiyu Pharmaceutical Business Overview Table 130. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 132. Chengdu Baiyu Pharmaceutical Recent Development Table 133. Techdow (Hepalink) Company Information Table 134. Techdow (Hepalink) Business Overview Table 135. Techdow (Hepalink) Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio Table 137. Techdow (Hepalink) Recent Development Table 138. Taj Pharma Company Information Table 139. Taj Pharma Business Overview Table 140. Taj Pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Taj Pharma Enoxaparin Sodium Injection Product Portfolio Table 142. Taj Pharma Recent Development Table 143. Rovi Company Information Table 144. Rovi Business Overview Table 145. Rovi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Rovi Enoxaparin Sodium Injection Product Portfolio Table 147. Rovi Recent Development Table 148. Cipla Company Information Table 149. Cipla Business Overview Table 150. Cipla Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Cipla Enoxaparin Sodium Injection Product Portfolio Table 152. Cipla Recent Development Table 153. Apotex Company Information Table 154. Apotex Business Overview Table 155. Apotex Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Apotex Enoxaparin Sodium Injection Product Portfolio Table 157. Apotex Recent Development Table 158. Amphastar Company Information Table 159. Amphastar Business Overview Table 160. Amphastar Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Amphastar Enoxaparin Sodium Injection Product Portfolio Table 162. Amphastar Recent Development Table 163. North America Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. North America Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 165. North America Enoxaparin Sodium Injection Sales Market Share by Country (2021-2026) Table 166. North America Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032) & (K Units) Table 167. North America Enoxaparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 168. North America Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Enoxaparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Enoxaparin Sodium Injection Market Share by Country (2021-2026) Table 171. North America Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Enoxaparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 173. Europe Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Europe Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 175. Europe Enoxaparin Sodium Injection Sales Market Share by Country (2021-2026) Table 176. Europe Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032) & (K Units) Table 177. Europe Enoxaparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 178. Europe Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Enoxaparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Enoxaparin Sodium Injection Market Share by Country (2021-2026) Table 181. Europe Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Enoxaparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 185. Asia-Pacific Enoxaparin Sodium Injection Sales Market Share by Country (2021-2026) Table 186. Asia-Pacific Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032) & (K Units) Table 187. Asia-Pacific Enoxaparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Enoxaparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Enoxaparin Sodium Injection Market Share by Country (2021-2026) Table 191. Asia-Pacific Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Enoxaparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 193. Latin America Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 194. Latin America Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 195. Latin America Enoxaparin Sodium Injection Sales Market Share by Country (2021-2026) Table 196. Latin America Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032) & (K Units) Table 197. Latin America Enoxaparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 198. Latin America Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Latin America Enoxaparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 200. Latin America Enoxaparin Sodium Injection Market Share by Country (2021-2026) Table 201. Latin America Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Latin America Enoxaparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 203. Middle East and Africa Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 204. Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 205. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share by Country (2021-2026) Table 206. Middle East and Africa Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032) & (K Units) Table 207. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share Forecast by Country (2027-2032) Table 208. Middle East and Africa Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Middle East and Africa Enoxaparin Sodium Injection Market Size by Country (2021-2026) & (US$ Million) Table 210. Middle East and Africa Enoxaparin Sodium Injection Market Share by Country (2021-2026) Table 211. Middle East and Africa Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Middle East and Africa Enoxaparin Sodium Injection Market Share Forecast by Country (2027-2032) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Enoxaparin Sodium Injection Distributors List Table 216. Enoxaparin Sodium Injection Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Injection Image Figure 2. Global Enoxaparin Sodium Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Enoxaparin Sodium Injection Sales (2021-2032) & (K Units) Figure 5. 100 mg/1mL Image Figure 6. Global 100 mg/1mL Sales YoY Growth (2021-2032) & (K Units) Figure 7. 120 mg/0.8mL Image Figure 8. Global 120 mg/0.8mL Sales YoY Growth (2021-2032) & (K Units) Figure 9. 150 mg/1mL Image Figure 10. Global 150 mg/1mL Sales YoY Growth (2021-2032) & (K Units) Figure 11. 20 mg/0.2mL Image Figure 12. Global 20 mg/0.2mL Sales YoY Growth (2021-2032) & (K Units) Figure 13. 30 mg/0.3mL Image Figure 14. Global 30 mg/0.3mL Sales YoY Growth (2021-2032) & (K Units) Figure 15. 300mg/3mL Image Figure 16. Global 300mg/3mL Sales YoY Growth (2021-2032) & (K Units) Figure 17. 40 mg/0.4mL Image Figure 18. Global 40 mg/0.4mL Sales YoY Growth (2021-2032) & (K Units) Figure 19. 60 mg/0.6mL Image Figure 20. Global 60 mg/0.6mL Sales YoY Growth (2021-2032) & (K Units) Figure 21. 80 mg/0.8mL Image Figure 22. Global 80 mg/0.8mL Sales YoY Growth (2021-2032) & (K Units) Figure 23. Global Enoxaparin Sodium Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 24. Global Enoxaparin Sodium Injection Market Share by Type 2025 VS 2032 Figure 25. North America Enoxaparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 26. North America Enoxaparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 27. Europe Enoxaparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 28. Europe Enoxaparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 29. Asia-Pacific Enoxaparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 30. Asia-Pacific Enoxaparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 31. Latin America Enoxaparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 32. Latin America Enoxaparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 33. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share in Volume by Type in 2025 Figure 34. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share in Value by Type in 2025 Figure 35. Global Top 5 and 10 Enoxaparin Sodium Injection Players Market Share by Revenue in 2025 Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 37. Hospital Image Figure 38. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 39. Clinic Image Figure 40. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 41. Others Image Figure 42. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 43. Global Enoxaparin Sodium Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Enoxaparin Sodium Injection Market Share by Application 2025 VS 2032 Figure 45. North America Enoxaparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 46. North America Enoxaparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 47. Europe Enoxaparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 48. Europe Enoxaparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Enoxaparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Enoxaparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 51. Latin America Enoxaparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Enoxaparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share in Value by Application in 2025 Figure 55. North America Enoxaparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. North America Enoxaparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Enoxaparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Enoxaparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Europe Enoxaparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Enoxaparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Enoxaparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Asia-Pacific Enoxaparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Enoxaparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Enoxaparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Latin America Enoxaparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Enoxaparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Enoxaparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Middle East and Africa Enoxaparin Sodium Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Enoxaparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Enoxaparin Sodium Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Enoxaparin Sodium Injection Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Enoxaparin Sodium Injection Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 300mg/3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Suzhou Erye Pharmaceutical
  • Sandoz
  • Sanofi
  • Nanjing King-friend
  • Hangzhou Jiuyuan Gene Engineering
  • Hebei Changshan Biochemical Pharmaceutical
  • Fresenius Kabi
  • Changzhou Qianhong Bio-pharma
  • Beijing SL Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Techdow (Hepalink)
  • Taj Pharma
  • Rovi
  • Cipla
  • Apotex
  • Amphastar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enoxaparin Sodium Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Enoxaparin Sodium Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Enoxaparin Sodium Injection Market by Type
  6. 1.3.1 100 mg/1mL
  7. 1.3.2 120 mg/0.8mL
  8. 1.3.3 150 mg/1mL
  9. 1.3.4 20 mg/0.2mL
  10. 1.3.5 30 mg/0.3mL
  11. 1.3.6 300mg/3mL
  12. 1.3.7 40 mg/0.4mL
  13. 1.3.8 60 mg/0.6mL
  14. 1.3.9 80 mg/0.8mL
  15. 1.4 Global Enoxaparin Sodium Injection Market Size by Type
  16. 1.4.1 Global Enoxaparin Sodium Injection Market Size Overview by Type (2021-2032)
  17. 1.4.2 Global Enoxaparin Sodium Injection Historic Market Size Review by Type (2021-2026)
  18. 1.4.3 Global Enoxaparin Sodium Injection Forecasted Market Size by Type (2027-2032)
  19. 1.5 Key Regions Market Size by Type
  20. 1.5.1 North America Enoxaparin Sodium Injection Sales Breakdown by Type (2021-2026)
  21. 1.5.2 Europe Enoxaparin Sodium Injection Sales Breakdown by Type (2021-2026)
  22. 1.5.3 Asia-Pacific Enoxaparin Sodium Injection Sales Breakdown by Type (2021-2026)
  23. 1.5.4 South America Enoxaparin Sodium Injection Sales Breakdown by Type (2021-2026)
  24. 1.5.5 Middle East and Africa Enoxaparin Sodium Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Enoxaparin Sodium Injection Industry Trends
  2. 2.2 Enoxaparin Sodium Injection Industry Drivers
  3. 2.3 Enoxaparin Sodium Injection Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Enoxaparin Sodium Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Enoxaparin Sodium Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Enoxaparin Sodium Injection Price (2021-2026)
  4. 3.4 Global Enoxaparin Sodium Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enoxaparin Sodium Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Enoxaparin Sodium Injection Company, Product Type & Application
  7. 3.7 Global Enoxaparin Sodium Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enoxaparin Sodium Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enoxaparin Sodium Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enoxaparin Sodium Injection Tier 1, Tier 2, and Tier 3
4 Enoxaparin Sodium Injection Regional Status and Outlook
  1. 4.1 Global Enoxaparin Sodium Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Enoxaparin Sodium Injection Historic Market Size by Region
  3. 4.2.1 Global Enoxaparin Sodium Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Enoxaparin Sodium Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Enoxaparin Sodium Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Enoxaparin Sodium Injection Forecasted Market Size by Region
  7. 4.3.1 Global Enoxaparin Sodium Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Enoxaparin Sodium Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Enoxaparin Sodium Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Enoxaparin Sodium Injection by Application
  1. 5.1 Enoxaparin Sodium Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Enoxaparin Sodium Injection Market Size by Application
  6. 5.2.1 Global Enoxaparin Sodium Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Enoxaparin Sodium Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Enoxaparin Sodium Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Enoxaparin Sodium Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Enoxaparin Sodium Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Enoxaparin Sodium Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Enoxaparin Sodium Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Enoxaparin Sodium Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Enoxaparin Sodium Injection Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Suzhou Erye Pharmaceutical
  8. 6.2.1 Suzhou Erye Pharmaceutical Company Information
  9. 6.2.2 Suzhou Erye Pharmaceutical Business Overview
  10. 6.2.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  12. 6.2.5 Suzhou Erye Pharmaceutical Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz Enoxaparin Sodium Injection Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Enoxaparin Sodium Injection Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Nanjing King-friend
  26. 6.5.1 Nanjing King-friend Company Information
  27. 6.5.2 Nanjing King-friend Business Overview
  28. 6.5.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio
  30. 6.5.5 Nanjing King-friend Recent Developments
  31. 6.6 Hangzhou Jiuyuan Gene Engineering
  32. 6.6.1 Hangzhou Jiuyuan Gene Engineering Company Information
  33. 6.6.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  34. 6.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio
  36. 6.6.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  37. 6.7 Hebei Changshan Biochemical Pharmaceutical
  38. 6.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  39. 6.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  40. 6.7.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  42. 6.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  43. 6.8 Fresenius Kabi
  44. 6.8.1 Fresenius Kabi Company Information
  45. 6.8.2 Fresenius Kabi Business Overview
  46. 6.8.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio
  48. 6.8.5 Fresenius Kabi Recent Developments
  49. 6.9 Changzhou Qianhong Bio-pharma
  50. 6.9.1 Changzhou Qianhong Bio-pharma Company Information
  51. 6.9.2 Changzhou Qianhong Bio-pharma Business Overview
  52. 6.9.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio
  54. 6.9.5 Changzhou Qianhong Bio-pharma Recent Developments
  55. 6.10 Beijing SL Pharmaceutical
  56. 6.10.1 Beijing SL Pharmaceutical Company Information
  57. 6.10.2 Beijing SL Pharmaceutical Business Overview
  58. 6.10.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  60. 6.10.5 Beijing SL Pharmaceutical Recent Developments
  61. 6.11 Chengdu Baiyu Pharmaceutical
  62. 6.11.1 Chengdu Baiyu Pharmaceutical Company Information
  63. 6.11.2 Chengdu Baiyu Pharmaceutical Business Overview
  64. 6.11.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  66. 6.11.5 Chengdu Baiyu Pharmaceutical Recent Developments
  67. 6.12 Techdow (Hepalink)
  68. 6.12.1 Techdow (Hepalink) Company Information
  69. 6.12.2 Techdow (Hepalink) Business Overview
  70. 6.12.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio
  72. 6.12.5 Techdow (Hepalink) Recent Developments
  73. 6.13 Taj Pharma
  74. 6.13.1 Taj Pharma Company Information
  75. 6.13.2 Taj Pharma Business Overview
  76. 6.13.3 Taj Pharma Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Taj Pharma Enoxaparin Sodium Injection Product Portfolio
  78. 6.13.5 Taj Pharma Recent Developments
  79. 6.14 Rovi
  80. 6.14.1 Rovi Company Information
  81. 6.14.2 Rovi Business Overview
  82. 6.14.3 Rovi Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Rovi Enoxaparin Sodium Injection Product Portfolio
  84. 6.14.5 Rovi Recent Developments
  85. 6.15 Cipla
  86. 6.15.1 Cipla Company Information
  87. 6.15.2 Cipla Business Overview
  88. 6.15.3 Cipla Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Cipla Enoxaparin Sodium Injection Product Portfolio
  90. 6.15.5 Cipla Recent Developments
  91. 6.16 Apotex
  92. 6.16.1 Apotex Company Information
  93. 6.16.2 Apotex Business Overview
  94. 6.16.3 Apotex Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Apotex Enoxaparin Sodium Injection Product Portfolio
  96. 6.16.5 Apotex Recent Developments
  97. 6.17 Amphastar
  98. 6.17.1 Amphastar Company Information
  99. 6.17.2 Amphastar Business Overview
  100. 6.17.3 Amphastar Enoxaparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Amphastar Enoxaparin Sodium Injection Product Portfolio
  102. 6.17.5 Amphastar Recent Developments
7 North America by Country
  1. 7.1 North America Enoxaparin Sodium Injection Sales by Country
  2. 7.1.1 North America Enoxaparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Enoxaparin Sodium Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Enoxaparin Sodium Injection Market Size by Country
  6. 7.2.1 North America Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Enoxaparin Sodium Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Enoxaparin Sodium Injection Sales by Country
  2. 8.1.1 Europe Enoxaparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Enoxaparin Sodium Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Enoxaparin Sodium Injection Market Size by Country
  6. 8.2.1 Europe Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Enoxaparin Sodium Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Enoxaparin Sodium Injection Sales by Country
  2. 9.1.1 Asia-Pacific Enoxaparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Enoxaparin Sodium Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Enoxaparin Sodium Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Enoxaparin Sodium Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Enoxaparin Sodium Injection Sales by Country
  2. 10.1.1 South America Enoxaparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Enoxaparin Sodium Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Enoxaparin Sodium Injection Market Size by Country
  6. 10.2.1 South America Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Enoxaparin Sodium Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Enoxaparin Sodium Injection Sales by Country
  2. 11.1.1 Middle East and Africa Enoxaparin Sodium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Enoxaparin Sodium Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Enoxaparin Sodium Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Enoxaparin Sodium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Enoxaparin Sodium Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Enoxaparin Sodium Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Enoxaparin Sodium Injection Value Chain Analysis
  2. 12.1.1 Enoxaparin Sodium Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Enoxaparin Sodium Injection Production Mode & Process
  7. 12.2 Enoxaparin Sodium Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Enoxaparin Sodium Injection Distributors
  10. 12.2.3 Enoxaparin Sodium Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst